Trials / Active Not Recruiting
Active Not RecruitingNCT01829958
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the ability of a largely self-administered geriatric assessment (GA) to predict toxicity in non-Hodgkin Lymphoma (NHL) patients ≥60 years old receiving chemotherapy or chemoimmunotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rituximab | |
| DRUG | prednisone | |
| BEHAVIORAL | Geriatric Assessment |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2013-04-11
- Last updated
- 2025-05-06
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01829958. Inclusion in this directory is not an endorsement.